BRIEF-Neptune and Ingenutra signs exclusive worldwide agreement for MaxSimil

Fri Oct 7, 2016 8:37am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Oct 7 (Reuters) - Neptune Technologies & Bioressources Inc

* Terms also cover potential collaboration between both companies on clinical trials

* Neptune Technologies & Bioressources Inc says all other terms of agreement remain confidential

* Neptune and Ingenutra sign an exclusive worldwide agreement for Maxsimil

* All other terms of agreement remain confidential.

* Agreement allows neptune to manufacture, distribute and sell Maxsimil in nutraceutical field worldwide

* Says agreement is valid till 2028 Source text for Eikon: Further company coverage: